Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02241954 · ClinicalTrials.gov registry record
Vertical Expandable Prosthetic Titanium Rib (VEPTR) for Thoracic Insufficiency Syndrome
A clinical trial, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- 7
- Enrollment target
NCT02241954 is a clinical trial that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 7 participants.
The verdict
NCT02241954 has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- 7 participants
- Enrollment target
Study Summary
The hypothesis of the study is that individuals with poor pulmonary function secondary to TIS will benefit from expansion thoracoplasty. The investigators specific aims are to: 1. Record pulmonary function and thoracic volume of TIS patients at enrollment and with serial observation 2. Offer expansion thoracoplasty therapy to TIS patients with 1. poor pulmonary function at enrollment 2. progressive decline in pulmonary function 3. progressive chest wall and/or spinal deformity 4. lack of appropriate increase in thoracic volume during growth 3. Document efficacy of expansion thoracoplasty for TIS patients
Interventions
- DEVICE Synthes VEPTR (Vertical Expandable Prosthetic Titanium Rib)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2010-11-11 |
| Est. Completion | 2020-02-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02241954
The ClinicalTrials.gov registry entry for NCT02241954 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Synthes VEPTR (Vertical Expandable Prosthetic Titanium Rib) is the first listed.
NCT02241954 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02241954 about?
NCT02241954 is a clinical study titled "Vertical Expandable Prosthetic Titanium Rib (VEPTR) for Thoracic Insufficiency Syndrome". The hypothesis of the study is that individuals with poor pulmonary function secondary to TIS will benefit from expansion thoracoplasty. The investigators specific aims are to: 1. Record pulmonary function and thoracic volume of TIS patients at enrollment and with serial observation 2. Offer expans...
What is the current status of trial NCT02241954?
This trial is currently completed. The enrollment target is 7 participants. The study started on 2010-11-11. Estimated completion is 2020-02-28.
What interventions are being tested in trial NCT02241954?
The interventions under investigation include: Synthes VEPTR (Vertical Expandable Prosthetic Titanium Rib) (DEVICE).
Who is sponsoring clinical trial NCT02241954?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.